Anxiety-related behaviors in cholecystokinin-A, B, and AB receptor gene knockout mice in the plus-maze

被引:38
作者
Miyasaka, K
Kobayashi, S
Ohta, M
Kanai, S
Yoshida, Y
Nagata, A
Matsui, T
Noda, T
Takiguchi, S
Takata, Y
Kawanami, T
Funakoshi, A
机构
[1] Tokyo Metropolitan Inst Gerontol, Dept Clin Physiol, Tokyo 1730015, Japan
[2] Tokyo Metropolitan Inst Gerontol, Dept Cell Recognit, Tokyo 1730015, Japan
[3] Kobe Univ, Sch Med, Third Div, Dept Med, Kobe, Hyogo 650, Japan
[4] Tohoku Univ, Sch Med, Dept Mol Genet, Sendai, Miyagi 9808575, Japan
[5] Kyushu Natl Canc Ctr, Res Inst, Fukuoka 8111395, Japan
[6] Kyushu Natl Canc Ctr, Dept Gastroenterol, Fukuoka 8111395, Japan
关键词
behavior; cholecystokinin; cholecystokinin-A receptor; cholecystokinin-B receptor; anxiety;
D O I
10.1016/S0304-3940(02)01176-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cholecystokinin (CCK)-A receptor (AR) and B receptor (BR) share highly amino acid sequence homology and overlap in their tissue distribution. We examined the anxiety-related behavior of CCK-AR, CCK-BR, and CCK-ARBR gene knockout (-/-) mice in the elevated plus-maze. CCK-AR(-/-) mice showed a significantly higher frequency of open-arm entries than wild-type and CCK-BR(-/-) mice, whereas the percentage open-arm entry values in CCK-AR(-/-) mice did not differ from those in wild-type mice. Thus, this increased frequency in open-arm entries for CCK-AR(-/-) mice was interpreted to be due to an increase in locomotor activity, rather than to a reduction in anxiety. By contrast, CCK-BR(-/-) mice showed significantly lower percentage open-arm entry values and spent significantly less time in the open- arms than wild-type and CCK-AR(-/-) mice. We therefore conclude that a lack of CCK-BR increases the anxiety-related behavior of the mouse in the elevated plus- maze. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:115 / 118
页数:4
相关论文
共 19 条
[1]   Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models [J].
Ballaz, S ;
Barber, A ;
Fortuno, A ;
DelRio, J ;
MartinMartinez, M ;
GomezMonterrey, I ;
Herranz, R ;
GonzalezMuniz, R ;
GarciaLopez, MT .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (04) :759-767
[2]   ETHOPHARMACOLOGICAL ANALYSIS OF RAT BEHAVIOR ON THE ELEVATED PLUS-MAZE [J].
CRUZ, APM ;
FREI, F ;
GRAEFF, FG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (01) :171-176
[3]   LACK OF EFFECT OF CCKB RECEPTOR ANTAGONISTS IN ETHOLOGICAL AND CONDITIONED ANIMAL SCREENS FOR ANXIOLYTIC DRUGS [J].
DAWSON, GR ;
RUPNIAK, NMJ ;
IVERSEN, SD ;
CURNOW, R ;
TYE, S ;
STANHOPE, KJ ;
TRICKLEBANK, MD .
PSYCHOPHARMACOLOGY, 1995, 121 (01) :109-117
[4]  
FODGERS RJ, 1995, PHARM BIOCH BEHAV, V50, P297
[5]   Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism [J].
Funakoshi, A ;
Miyasaka, K ;
Matsumoto, H ;
Yamamori, S ;
Takiguchi, S ;
Kataoka, K ;
Takata, Y ;
Matsusue, K ;
Kono, A ;
Shimokata, H .
FEBS LETTERS, 2000, 466 (2-3) :264-266
[6]  
HILL DR, 1987, J NEUROSCI, V7, P2967
[7]   DIFFERENTIAL GENE-EXPRESSION OF CCK(A) AND CCK(B) RECEPTORS IN THE RAT-BRAIN [J].
HONDA, T ;
WADA, E ;
BATTEY, JF ;
WANK, SA .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1993, 4 (02) :143-154
[8]   DEVELOPMENT OF A CLASS OF SELECTIVE CHOLECYSTOKININ TYPE-B RECEPTOR ANTAGONISTS HAVING POTENT ANXIOLYTIC ACTIVITY [J].
HUGHES, J ;
BODEN, P ;
COSTALL, B ;
DOMENEY, A ;
KELLY, E ;
HORWELL, DC ;
HUNTER, JC ;
PINNOCK, RD ;
WOODRUFF, GN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6728-6732
[9]   Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice [J].
Johnson, NJT ;
Rodgers, RJ .
PSYCHOPHARMACOLOGY, 1996, 124 (04) :355-364
[10]  
Kobayashi S, 1996, NEUROSCI LETT, V214, P61